Acquired · UK
Biotech · B2B
Clinical trial supply and dosing systems
Endpoint Clinical builds the systems that control how clinical trials are supplied and how patients are dosed, delivered through its PULSE platform. Trials fail expensively when drug supply is mispositioned or dosing instructions arrive late, so the software works to maximise the supply chain, hold operational costs down and keep dosing timely and accurate across sites. Its customers are pharmaceutical and biotechnology sponsors along with the contract and academic research organisations running studies for them. The company is headquartered in Raleigh-Durham, North Carolina, with offices across the United States, Europe and Asia.
endpointclinical.com (opens in a new tab)No open roles right now
Endpoint Clinical has nothing open on the board today. We've tracked 4 roles here so far, and new ones show up here on their own.
Explore all roles